Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 760368, 10 pages
http://dx.doi.org/10.1155/2014/760368
Research Article

Ouabain Affects the Expression of Activation Markers, Cytokine Production, and Endocytosis of Human Monocytes

Laboratório de Imunologia Tumoral, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, H2003 Cidade Universitária, Ilha do Fundão, 21941-590 Rio de Janeiro, Brazil

Received 18 January 2014; Accepted 3 March 2014; Published 8 May 2014

Academic Editor: Hidde Bult

Copyright © 2014 Mariana Pires Teixeira and Vivian Mary Rumjanek. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Schoner, “Endogenous cardiac glycosides, a new class of steroid hormones,” European Journal of Biochemistry, vol. 269, no. 10, pp. 2440–2448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Hamlyn, M. P. Blaustein, S. Bova et al., “Identification and characterization of a ouabain-like compound from human plasma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, pp. 6259–6263, 1991. View at Google Scholar
  3. R. Antolovic, N. Bauer, M. Mohadjerani et al., “Endogenous ouabain and its binding globulin: effects of physical exercise and study on the globulin's tissue distribution,” Hypertension Research, vol. 23, supplement, pp. S93–S98, 2000. View at Google Scholar · View at Scopus
  4. S. S. Gottlieb, A. C. Rogowski, M. Weinberg, C. M. Krichten, B. P. Hamilton, and J. M. Hamlyn, “Elevated concentrations of endogenous ouabain in patients with congestive heart failure,” Circulation, vol. 86, no. 2, pp. 420–425, 1992. View at Google Scholar · View at Scopus
  5. N. Bauer, J. Müller-Ehmsen, U. Krämer et al., “Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β-blockade and angiotensin-converting enzyme inhibition,” Hypertension, vol. 45, no. 5, pp. 1024–1028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Goto, K. Yamada, H. Nagoshi, Y. Terano, and M. Omata, “Stress-induced elevation of ouabainlike compound in rat plasma and adrenal,” Hypertension, vol. 26, no. 6, pp. 1173–1176, 1995. View at Google Scholar · View at Scopus
  7. A. Y. Bagrov and J. I. Shapiro, “Endogenous digitalis: pathophysiologic roles and therapeutic applications,” Nature Clinical Practice Nephrology, vol. 4, no. 7, pp. 378–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Hamlyn and M. P. Blaustein, “Salt sensitivity, endogenous ouabain and hypertension,” Current Opinion in Nephrology and Hypertension, vol. 22, pp. 51–58, 2013. View at Google Scholar
  9. P. Manunta, P. Stella, R. Rivera et al., “Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension,” Hypertension, vol. 34, no. 3, pp. 450–456, 1999. View at Google Scholar · View at Scopus
  10. W. Schoner, N. Bauer, J. Müller-Ehmsen et al., “Ouabain as a mammalian hormone,” Annals of the New York Academy of Sciences, vol. 986, pp. 678–684, 2003. View at Google Scholar · View at Scopus
  11. E. Féraille and A. Doucet, “Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control,” Physiological Reviews, vol. 81, no. 1, pp. 345–418, 2001. View at Google Scholar · View at Scopus
  12. W. Schoner and G. Scheiner-Bobis, “Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth,” American Journal of Physiology. Cell Physiology, vol. 293, no. 2, pp. C509–C536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Lingrel, “The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase,” Annual Review of Physiology, vol. 72, pp. 395–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Rodrigues-Mascarenhas, A. D. S. de Oliveira, N. D. Amoedo, O. R. Affonso-Mitidieri, F. D. Rumjanek, and V. M. Rumjanek, “Modulation of the immune system by ouabain,” Annals of the New York Academy of Sciences, vol. 1153, pp. 153–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. de Paiva, K. M. D. Costa, F. B. D. Canto et al., “Modulation of mature B cells in mice following treatment with ouabain,” Immunobiology, vol. 216, no. 9, pp. 1038–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. I. B. de Vasconcelos, J. A. Leite, L. T. Carneiro et al., “Anti-inflammatory and antinociceptive activity of ouabain in mice,” Mediators of Inflammation, vol. 2011, Article ID 912925, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. L. Jacob, J. A. Leite, A. K. Alves et al., “Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice,” Parasitology Research, vol. 112, pp. 1313–1321, 2013. View at Google Scholar
  18. A. D. Foey, A. Crawford, and N. D. Hall, “Modulation of cytokine production by human mononuclear cells following impairment of Na,K-ATPase activity,” Biochimica et Biophysica Acta. Molecular Cell Research, vol. 1355, no. 1, pp. 43–49, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Matsumori, K. Ono, R. Nishio et al., “Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain,” Circulation, vol. 96, no. 5, pp. 1501–1506, 1997. View at Google Scholar · View at Scopus
  20. A. Matsumori, K. Ono, R. Nishio, Y. Nose, and S. Sasayama, “Amlodipine inhibits the production of cytokines induced by ouabain,” Cytokine, vol. 12, no. 3, pp. 294–297, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. R. C. Valente, C. R. Nascimento, E. G. Araujo, and V. M. Rumjanek, “mCD14 expression in human monocytes is downregulated by ouabain via transactivation of epithelial growth factor receptor and activation of p38 mitogen-activated protein kinase,” Neuroimmunomodulation, vol. 16, no. 4, pp. 228–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Saha and F. Geissmann, “Toward a functional characterization of blood monocytes,” Immunology and Cell Biology, vol. 89, no. 1, pp. 2–4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Farina, D. Theil, B. Semlinger, R. Hohlfeld, and E. Meinl, “Distinct responses to monocytes to Toll-like receptor ligands and inflammatory cytokines,” International Immunology, vol. 16, no. 6, pp. 799–809, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Bromley, A. Iaboni, S. J. Davis et al., “The immunological synapse and CD28–CD80 interactions,” Nature Immunology, vol. 2, no. 12, pp. 1159–1166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Wollenberg, M. Mommaas, T. Oppel, E.-M. Schottdorf, S. Günther, and M. Moderer, “Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases,” Journal of Investigative Dermatology, vol. 118, no. 2, pp. 327–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Auffray, M. H. Sieweke, and F. Geissmann, “Blood monocytes: development, heterogeneity, and relationship with dendritic cells,” Annual Review of Immunology, vol. 27, pp. 669–692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Geissmann, M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley, “Development of monocytes, macrophages, and dendritic cells,” Science, vol. 327, no. 5966, pp. 656–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Tacke and G. J. Randolph, “Migratory fate and differentiation of blood monocyte subsets,” Immunobiology, vol. 211, no. 6–8, pp. 609–618, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Grage-Griebenow, H.-D. Flad, and M. Ernst, “Heterogeneity of human peripheral blood monocyte subsets,” Journal of Leukocyte Biology, vol. 69, no. 1, pp. 11–20, 2001. View at Google Scholar · View at Scopus
  30. S. Gordon and P. R. Taylor, “Monocyte and macrophage heterogeneity,” Nature Reviews Immunology, vol. 5, no. 12, pp. 953–964, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Chow, B. D. Brown, and M. Merad, “Studying the mononuclear phagocyte system in the molecular age,” Nature Reviews Immunology, vol. 11, no. 11, pp. 788–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Wikman, A. Fagergren, S. G. O. Johansson, J. Lundahl, and S. H. Jacobson, “Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis,” Nephrology Dialysis Transplantation, vol. 18, no. 9, pp. 1792–1799, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. K. A. Armah, K. McGinnis, J. Baker et al., “HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation,” Clinical Infectious Diseases, vol. 55, pp. 126–136, 2012. View at Google Scholar
  34. M. Kato, T. K. Nell, D. B. Fearnley, A. D. McLellan, S. Vuckovic, and D. N. J. Hart, “Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells,” International Immunology, vol. 12, no. 11, pp. 1511–1519, 2000. View at Google Scholar · View at Scopus
  35. Z. Xie, “Molecular mechanisms of Na/K-ATPase-mediated signal transduction,” Annals of the New York Academy of Sciences, vol. 986, pp. 497–503, 2003. View at Google Scholar · View at Scopus
  36. L. de Sá Lima, E. M. Kawamoto, C. D. Munhoz et al., “Ouabain activates NFκB through an NMDA signaling pathway in cultured cerebellar cells,” Neuropharmacology, vol. 73, pp. 327–336, 2013. View at Google Scholar
  37. L. Zhang, Z. Zhang, H. Guo, and Y. Wang, “Na+/K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation,” Fundamental and Clinical Pharmacology, vol. 22, no. 6, pp. 615–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Wu, E. E. Akkuratov, Y. Bai, C. M. Gaskill, A. Askari, and L. Liu, “Cell signaling associated with Na+/K+-ATPase: activation of phosphatidylinositide 3-kinase IA/Akt by ouabain is independent of src,” Biochemistry, vol. 52, pp. 9059–9067, 2013. View at Google Scholar